Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    14506209 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Antimalarial Drug Resistance in Mali
Condition: Malaria
Interventions: Drug: chloroquine;   Drug: sulfadoxine-pyrimethamine;   Drug: amodiaquine;   Drug: amodiaquine+artesunate;   Drug: amodiaquine+sulfadoxine-pyrimethamine;   Drug: sulfadoxine-pyrimethamine+artesunate;   Drug: artemether-lumefantrine;   Drug: mefloquine

Indicates status has not been verified in more than two years